These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 32448377)

  • 1. Stem cell therapy: a potential approach for treatment of influenza virus and coronavirus-induced acute lung injury.
    Du J; Li H; Lian J; Zhu X; Qiao L; Lin J
    Stem Cell Res Ther; 2020 May; 11(1):192. PubMed ID: 32448377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic potential of mesenchymal stem cell-derived extracellular vesicles in SARS-CoV-2 and H1N1 influenza-induced acute lung injury.
    Lee JH; Jeon H; Lötvall J; Cho BS
    J Extracell Vesicles; 2024 Sep; 13(9):e12495. PubMed ID: 39254228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone marrow-derived mesenchymal stem cells attenuate pulmonary inflammation and lung damage caused by highly pathogenic avian influenza A/H5N1 virus in BALB/c mice.
    Yudhawati R; Amin M; Rantam FA; Prasetya RR; Dewantari JR; Nastri AM; Poetranto ED; Wulandari L; Lusida MI; Koesnowidagdo S; Soegiarto G; Shimizu YK; Mori Y; Shimizu K
    BMC Infect Dis; 2020 Nov; 20(1):823. PubMed ID: 33176722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential application of mesenchymal stem cells and their exosomes in lung injury: an emerging therapeutic option for COVID-19 patients.
    Al-Khawaga S; Abdelalim EM
    Stem Cell Res Ther; 2020 Oct; 11(1):437. PubMed ID: 33059757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current status of cell-based therapies for respiratory virus infections: applicability to COVID-19.
    Khoury M; Cuenca J; Cruz FF; Figueroa FE; Rocco PRM; Weiss DJ
    Eur Respir J; 2020 Jun; 55(6):. PubMed ID: 32265310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influenza causes prolonged disruption of the alveolar-capillary barrier in mice unresponsive to mesenchymal stem cell therapy.
    Gotts JE; Abbott J; Matthay MA
    Am J Physiol Lung Cell Mol Physiol; 2014 Sep; 307(5):L395-406. PubMed ID: 25038188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in Stem Cell and Cell-Based Gene Therapy Approaches for Experimental Acute Lung Injury: A Review of Preclinical Studies.
    Mei SH; Dos Santos CC; Stewart DJ
    Hum Gene Ther; 2016 Oct; 27(10):802-812. PubMed ID: 27531647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunomodulation of Mesenchymal Stem Cells in Acute Lung Injury: From Preclinical Animal Models to Treatment of Severe COVID-19.
    Li JP; Wu KH; Chao WR; Lee YJ; Yang SF; Chao YH
    Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35897770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Replication of Severe Acute Respiratory Syndrome Coronavirus 2 in Human Respiratory Epithelium.
    Milewska A; Kula-Pacurar A; Wadas J; Suder A; Szczepanski A; Dabrowska A; Owczarek K; Marcello A; Ochman M; Stacel T; Rajfur Z; Sanak M; Labaj P; Branicki W; Pyrc K
    J Virol; 2020 Jul; 94(15):. PubMed ID: 32434888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of C5a in acute lung injury induced by highly pathogenic viral infections.
    Wang R; Xiao H; Guo R; Li Y; Shen B
    Emerg Microbes Infect; 2015 May; 4(5):e28. PubMed ID: 26060601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesenchymal stem cells in acute lung injury: are they ready for translational medicine?
    Xu F; Hu Y; Zhou J; Wang X
    J Cell Mol Med; 2013 Aug; 17(8):927-35. PubMed ID: 23834470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Viral pathogens and acute lung injury: investigations inspired by the SARS epidemic and the 2009 H1N1 influenza pandemic.
    Hendrickson CM; Matthay MA
    Semin Respir Crit Care Med; 2013 Aug; 34(4):475-86. PubMed ID: 23934716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study on the role of apoptotic human umbilical cord mesenchymal stem cells in bleomycin-induced acute lung injury in rat models.
    Liu FB; Lin Q; Liu ZW
    Eur Rev Med Pharmacol Sci; 2016 Mar; 20(5):969-82. PubMed ID: 27010158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic Modification of Mesenchymal Stem Cells Overexpressing Angiotensin II Type 2 Receptor Increases Cell Migration to Injured Lung in LPS-Induced Acute Lung Injury Mice.
    Xu XP; Huang LL; Hu SL; Han JB; He HL; Xu JY; Xie JF; Liu AR; Liu SQ; Liu L; Huang YZ; Guo FM; Yang Y; Qiu HB
    Stem Cells Transl Med; 2018 Oct; 7(10):721-730. PubMed ID: 30133167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunomodulation and Regeneration Properties of Dental Pulp Stem Cells: A Potential Therapy to Treat Coronavirus Disease 2019.
    Zayed M; Iohara K
    Cell Transplant; 2020; 29():963689720952089. PubMed ID: 32830527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19: Catastrophic Cause of Acute Lung Injury.
    Cai A; McClafferty B; Benson J; Ramgobin D; Kalayanamitra R; Shahid Z; Groff A; Aggarwal CS; Patel R; Polimera H; Vunnam R; Golamari R; Sahu N; Bhatt D; Jain R
    S D Med; 2020 Jun; 73(6):252-260. PubMed ID: 32580257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA analysis of lung tissues after hUC-MSCs and FTY720 treatment of lipopolysaccharide-induced acute lung injury in mouse models.
    Zhang X; Liu H; Wang S; Huang Z; Wang H; Niu W; Qin Y; Bai C; Liu G; Chen H
    Int Immunopharmacol; 2019 Jun; 71():68-75. PubMed ID: 30877876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Geldanamycin Reduces Acute Respiratory Distress Syndrome and Promotes the Survival of Mice Infected with the Highly Virulent H5N1 Influenza Virus.
    Wang C; Liu P; Luo J; Ding H; Gao Y; Sun L; Luo F; Liu X; He H
    Front Cell Infect Microbiol; 2017; 7():267. PubMed ID: 28664154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pneumonia and the acute respiratory distress syndrome due to influenza A (H1N1) virus].
    López Cde H; Roca RF; Daunis JV
    Med Intensiva; 2009 Dec; 33(9):455-8. PubMed ID: 19854543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesenchymal stem cells induce dendritic cell immune tolerance via paracrine hepatocyte growth factor to alleviate acute lung injury.
    Lu Z; Chang W; Meng S; Xu X; Xie J; Guo F; Yang Y; Qiu H; Liu L
    Stem Cell Res Ther; 2019 Dec; 10(1):372. PubMed ID: 31801626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.